Treating Tobacco Dependence in Light of the 2008 US Department of Health and Human Services Clinical Practice Guideline

Division of General Internal Medicine, Mayo Clinic, Rochester, MN 55905, USA.
Mayo Clinic Proceedings (Impact Factor: 6.26). 09/2009; 84(8):730-5; quiz 735-6. DOI: 10.1016/S0025-6196(11)60523-5
Source: PubMed

ABSTRACT Cigarette smoking is the most important preventable cause of morbidity, mortality, and excess health care costs in the United States. From 2000 through 2004, cigarette smoking caused an estimated annual average of 443,595 deaths and cost $193 billion per year in smoking-attributable productivity losses and smoking-related health care expenditures. Preventing smoking and providing effective treatment to help smokers quit will remain a public health priority for the foreseeable future. In support of this goal, the US Department of Health and Human Services recently published the clinical practice guideline entitled Treating Tobacco Use and Dependence: 2008 Update. The new guideline updates the previous guidelines published in 1996 and 2000 and presents many new research findings to provide a broader evidence base for effective intervention. This article briefly reviews the major updates and recommendations from the new guideline and highlights its practical clinical applications.

5 Reads
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Objective. Although prevalence of tobacco smoking is different in the Latin American regions, the consequences on health are similar. Material and Methods. Therefore, guidelines on treatment are needed and ideally speaking must be useful in the different countries. In order to make quick recommendations useful in the region we made a search in PubMed from the last 5 years with the titles "Smoking cessation guidelines" and "Smoking cessation treatment meta-analysis" to know the content of different guidelines and with the titles of "Nicotine replacement therapy", "Nicotine chewing gum", "Nicotine patches", "Nicotine inhaler", "Bupropion therapy", "Varenicline therapy" and "Individual and grupal behavioural counselling for smoking cessation" to determine the efficacy of each intervention. Results and conclusion. Our recommendation based on the availability of pharmacotherapy and human resources is that medical advice and behavioural grupal counseling must be primary interventions either adding, or not, first line drugs for smoking cessation
    Salud publica de Mexico 12/2009; 52:S355-S365. DOI:10.1590/S0036-36342010000800034 · 0.94 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Smoking is the main isolated cause of preventable premature morbidity and mortality in developed countries. Smoking has been associated with a substantial rise in the risk of infarction through three main mechanisms: 1) the formation of carboxyhemoglobin and increase in hematocrit and blood viscosity, which produce carbon monoxide; 2) the action of nicotine, which releases adrenaline and noradrenaline, and 3) the absorption of a large amount of free radicals, which are involved in many prothrombotic and atherogenic mechanisms. Therefore, the offensive against smoking has produced an almost immediate effect on the population's health. Fortunately, there is a wide spectrum of effective interventions for smoking cessation, which can increase the possibility of success by up to 30%: minimal advice or brief intervention, psychological treatment and drug therapy.
    Clínica e Investigación en Arteriosclerosis 07/2010; 22(4). DOI:10.1016/j.arteri.2010.05.002
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The quantity and diversity of conceptual models in translational science may complicate rather than advance the use of theory. This paper offers a comparative thematic analysis of the models available to inform knowledge development, transfer, and utilization. Literature searches identified 47 models for knowledge translation. Four thematic areas emerged: (1) evidence-based practice and knowledge transformation processes, (2) strategic change to promote adoption of new knowledge, (3) knowledge exchange and synthesis for application and inquiry, and (4) designing and interpreting dissemination research. This analysis distinguishes the contributions made by leaders and researchers at each phase in the process of discovery, development, and service delivery. It also informs the selection of models to guide activities in knowledge translation. A flexible theoretical stance is essential to simultaneously develop new knowledge and accelerate the translation of that knowledge into practice behaviors and programs of care that support optimal patient outcomes.
    Nursing outlook 11/2010; 58(6):287-300. DOI:10.1016/j.outlook.2010.07.001 · 1.59 Impact Factor
Show more


5 Reads
Available from